These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23628947)

  • 1. Potential role of biventricular pacing beyond advanced systolic heart failure.
    Fang F; Sanderson JE; Yu CM
    Circ J; 2013; 77(6):1364-9. PubMed ID: 23628947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure.
    Mealing S; Woods B; Hawkins N; Cowie MR; Plummer CJ; Abraham WT; Beshai JF; Klein H; Sculpher M
    Heart; 2016 Nov; 102(21):1742-1749. PubMed ID: 27411837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac-resynchronization therapy in patients with systolic heart failure and QRS interval ≤130 ms: insights from a meta-analysis.
    Shah RM; Patel D; Molnar J; Ellenbogen KA; Koneru JN
    Europace; 2015 Feb; 17(2):267-73. PubMed ID: 25164431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
    Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term outcomes in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy.
    Rickard J; Gorodeski EZ; Patel D; Hussein A; Moennich LA; Cantillon D; Trulock K; Toro S; Niebauer M; Varma N; Wilkoff BL
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1979-1983. PubMed ID: 31211474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure.
    Osmanska J; Hawkins NM; Toma M; Ignaszewski A; Virani SA
    ESC Heart Fail; 2018 Aug; 5(4):668-674. PubMed ID: 29938922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of right ventriclular systolic function prior to cardiac resynchronization therapy: Does it make any difference?
    Abdelhamid MA; Ghanem MT; Abdelmotaleb AM
    Indian Heart J; 2017; 69(6):731-735. PubMed ID: 29174250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
    Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will biventricular pacing replace right ventricular pacing for antibradycardia therapy?
    Barold SS; Herweg B
    Expert Rev Med Devices; 2013 Sep; 10(5):591-6. PubMed ID: 24053252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of PR Interval on Outcomes Following Cardiac Resynchronization Therapy: A Secondary Analysis of the COMPANION Trial.
    Lin J; Buhr KA; Kipp R
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):185-191. PubMed ID: 27885751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QRS fusion complex analysis using wave interference to predict reverse remodeling during cardiac resynchronization therapy.
    Sweeney MO; Hellkamp AS; van Bommel RJ; Schalij MJ; Borleffs CJ; Bax JJ
    Heart Rhythm; 2014 May; 11(5):806-13. PubMed ID: 24462523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
    Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in non-left bundle branch block morphologies.
    Rickard J; Kumbhani DJ; Gorodeski EZ; Baranowski B; Wazni O; Martin DO; Grimm R; Wilkoff BL
    Pacing Clin Electrophysiol; 2010 May; 33(5):590-5. PubMed ID: 20025703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adaptive cardiac resynchronization therapy in patients with systolic heart failure: Beyond QRS duration and morphology.
    Fukata M; Yamasaki H; Sai E; Ogawa K; Kuroki K; Igarashi M; Sekiguchi Y; Kimura K; Seo Y; Odashiro K; Akashi K; Nogami A; Aonuma K
    J Cardiol; 2022 Mar; 79(3):365-370. PubMed ID: 34937673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of the PR Interval in Patients Receiving Cardiac Resynchronization Therapy: Results From the REVERSE Study.
    Senfield J; Daubert C; Abraham WT; Ghio S; St John Sutton M; Cerkvenik J; Linde C; Gold MR
    JACC Clin Electrophysiol; 2017 Aug; 3(8):818-826. PubMed ID: 29759777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.